[1]肖雄,赵晓彤,李乐,等.稳定表达VP5蛋白BGC823细胞系的构建[J].湖北工业大学学报,2024,39(4):61-65.
　XIAO Xiong,ZHAO Xiaotong,LI Le,et al.Construction of BGC823 Cell Line Stably Expressing VP5Protein of Herpes Simplex Virus Type Ⅱ[J].,2024,39(4):61-65.
点击复制

稳定表达VP5蛋白BGC823细胞系的构建()
分享到：

《湖北工业大学学报》[ISSN:1003-4684/CN:42-1752/Z]

卷:
39
期数:
2024年第4期
页码:
61-65
栏目:
出版日期:
2024-08-28

文章信息/Info

Title:
Construction of BGC823 Cell Line Stably Expressing VP5Protein of Herpes Simplex Virus Type Ⅱ
文章编号:
1003-4684(2024)04-0061-05
作者:
肖雄;  赵晓彤;  李乐;  周芹;  汪洋;  胡翰;  刘滨磊
(湖北工业大学生物工程与食品学院， 湖北 武汉 430068)
Author(s):
XIAO Xiong;  ZHAO Xiaotong; LI Le;  ZHOU Qin;  WANG Yang;  HU Han;  LIU Binlei
(School of Food and Biological Engin., Hubei Univ. of Tech., Wuhan 430068, China)
关键词:
溶瘤Ⅱ型单纯疱疹病毒;  VP5蛋白;  BGC823细胞
Keywords:
oncolytic herpes simplex virus type Ⅱ;  VP5 protein;  BGC823 cells
分类号:
R735.2
文献标志码:
A
摘要:
溶瘤Ⅱ型单纯疱疹病毒oHSV2是对Ⅱ型单纯疱疹病毒HSV2进行基因改造后得到的新型溶瘤病毒。UL19基因编码的VP5蛋白为oHSV2主要衣壳蛋白之一。在前期已经通过GST pulldown与质谱检测分析确定了oHSV2的VP5蛋白为人类白细胞抗原E（HLAE）的相互作用蛋白的基础上，将HLAE作为NK与CTL等免疫细胞表面CD94/NKG2A的强效抑制性配体，当它与CD94/NKG2A结合后，NK与CTL细胞的免疫功能会受到一定程度的抑制。前期研究已证实oHSV2会在体外上调部分肿瘤细胞系表面HLAE表达，为探究oHSV2是否通过VP5蛋白上调肿瘤细胞系表面HLAE的表达，进而影响HLAE和CD94/NKG2A的结合，最终改变NK细胞的抗肿瘤能力，通过PiggyBac 转座系统构建稳定表达VP5蛋白的人胃腺癌细胞BGC823VP5细胞系。所构建的细胞系经流式检测单克隆细胞阳性率在99%以上；Western Blot检测到VP5蛋白在细胞内表达；实时无标记动态细胞分析技术（RTCA Real Time Cell AnaIysis）检测表明BGC823VP5细胞系与亲本细胞BGC823细胞生长活性一致。稳定表达VP5蛋白的人胃癌细胞BGC823VP5细胞系的构建，为进一步研究oHSV2上VP5蛋白在人胃癌BGC823细胞内影响HLAE的表达，进而影响免疫细胞的抗肿瘤能力奠定了基础。
Abstract:
Oncolytic herpes simplex virus type Ⅱ oHSV2 is a new type of oncolytic virus obtained by genetic modification on the basis of herpes simplex virus type Ⅱ HSV2. VP5 protein encoded by UL19 gene is one of the main capsid proteins of oHSV2. Our team has determined that VP5 protein of oHSV2 is the interaction protein of human leukocyte antigen E (HLAE) through GST pull down and mass spectrometry detection and analysis in the early stage. HLAE is a potent inhibitory ligand of CD94/NKG2A on the surface of CTL cells and NK cells. When it binds with CD94/NKG2A, the immune function of CTL cells and NK cells will be inhibited. On the basis of previous studies that have confirmed that oHSV2 can up regulate the expression of HLAE on the surface of some tumor cell lines in vitro, in order to explore whether oHSV2 can up regulate the expression of HLAE on the surface of tumor cell lines through VP5 protein, thereby affecting the binding of HLAE and CD94/NKG2A, and ultimately changing the antitumor ability of NK cells, a human gastric adenocarcinoma cell line BGC823VP5 stably expressing VP5 was constructed through PiggyBac transposition system. The positive rate of monoclonal cells in the constructed cell line was more than 99% by flow cytometry; Western Blot detected VP5 protein expression in cells; RTCA Real Time Cell AnaIysis showed that the growth activity of BGC823VP5 cell line was consistent with that of its parent cell BGC823. The construction of a human gastric cancer cell line BGC823VP5 stably expressing VP5 lays a foundation for exploring the effect of VP5 protein on oHSV2 on the expression of HLAE in tumor cells and thus on the antitumor activity of NK cells.

参考文献/References:

［1］ZHANG W, ZENG B, HU X, et al. Oncolytic herpes simplex virus type 2 can effectively inhibit colorectal cancer liver metastasis by modulating the immune status in the tumor microenvironment and inducing specific antitumor immunity [J ]. Human gene therapy, 2021, 32(3 -4): 203 -215. [2 ]YUAN S, WANG J, ZHU D, et al. Cryo -EM structure of a herpesvirus capsid at 3.1  [J ]. Science (New York, NY), 2018, 360(6384):eaao7283. [3 ]LIEU P T, WAGNER E K. Two leaky -late HSV -1 promoters differ significantly in structural architecture [J ]. Virology, 2000, 272(01): 191 -203. [4 ]NATTERMANN J, NISCHALKE H D, HOFMEISTER V, et al. The HLA -A2 restricted T cell epitope HCV core 35 -44 stabilizes HLA -E expression and inhibits cytolysis mediated by natural killer cells [J ]. The American journal of pathology, 2005, 166(02): 443 -453. [5 ]PETRIE E J, CLEMENTS C S, LIN J, et al. CD94 -NKG2A recognition of human leukocyte antigen (HLA) -E bound to an HLA class I leader sequence [J ]. The Journal of experimental medicine, 2008, 205(03): 725 -735. [6 ]曹毛毛, 李贺, 孙殿钦, 等. 2000—2019年中国胃癌流行病学趋势分析 [J ]. 中华消化外科杂志, 2021, 20(01): 102 -109. [7 ]FU X, TAO L, ZHANG X. An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer [J ]. Cancer gene therapy, 2007, 14(05): 480 -487. [8 ]卢加琪, 韦薇, 白玉, 等. 细胞治疗产品的基因转导系统及审评要点 [J ]. 中国新药杂志，2020(01): 27 -32. [9 ]SAHA S, WOODARD L E, CHARRON E M, et al. Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells [J ]. Nucleic acids research, 2015, 43(03): 1770 -1782. [10 ] SARKAR A, SIM C, HONG Y S, et al. Molecular evolutionary analysis of the widespread piggyBac transposon family and related "domesticated" sequences [J ]. Molecular genetics and genomics : MGG, 2003, 270(02): 173 -180. [11 ] LOBO N F, FRASER T S, ADAMS J A, et al. Interplasmid transposition demonstrates piggyBac mobility in vertebrate species [J ]. Genetica, 2006, 128(1 -3): 347 -357. [12 ] PDELACQ J D, CABANTOUS S, TRAN T, et al. Engineering and characterization of a superfolder green fluorescent protein [J ]. Nature biotechnology, 2006, 24(01): 79 -88. [13 ] MARTINEZ -SERRA J, GUTIERREZ A, MUOZ -CAP S, et al. xCELLigence system for real -time label -free monitoring of growth and viability of cell lines from hematological malignancies [J ]. OncoTargets and therapy, 2014, 7: 985 -994. [14 ] ZHEN Z J, LING J Y, CAI Y, et al. Impact of HLA -E gene polymorphism on HLA -E expression in tumor cells and prognosis in patients with stage Ⅲ colorectal cancer [J ]. Medical oncology (Northwood, London, England), 2013, 30(01): 482. [15 ] ULBRECHT M, MARTINOZZI S, GRZESCHIK M, et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA -E and prevents NK cell -mediated lysis [J ]. Journal of immunology (Baltimore, Md : 1950), 2000, 164(10): 5019 -5022.

相似文献/References:

[1]姚若一,范嘉琦,肖　雄,等.HLA-E与oHSV2 VP5蛋白相互作用研究[J].湖北工业大学学报,2023,(5):82.
　YAO Ruoyi,FAN Jiaqi,XIAO Xiong,et al.Study on the Interaction Between HLAE and oHSV2 VP5 Protein[J].,2023,(4):82.
[2]范嘉琦,张慧,李乐,等.稳转oHSV2主要衣壳蛋白VP5人宫颈癌细胞系的构建[J].湖北工业大学学报,2024,39(4):50.
　FAN Jiaqi,ZHANG Hui,LI Le,et al.Construction of A Human Cervical Cancer Cell Line Containingthe Main Capsid Protein VP5 of Stable OncolyticHerpes Simplex Virus Type Ⅱ[J].,2024,39(4):50.

备注/Memo

备注/Memo:
［收稿日期］ 20221027［第一作者］ 肖雄（1998-）， 男， 湖北荆州人， 湖北工业大学硕士研究生， 研究方向为生物工程。［通信作者］ 刘滨磊（1962-）， 男， 湖北武汉人， 湖北工业大学教授， 研究方向为生物制药。
更新日期/Last Update: 2024-08-23